EKF Diagnostics Holdings Plc (EKF Diagnostics) is an in vitro diagnostics company that designs, develops, manufactures, and markets point-of-care (POC) devices and tests; and central laboratory products. Its POC range includes hemoglobin analyzers and HbA1c analyzers that can be used for screening, monitoring and diagnosing patients, and conducting tests for common infectious diseases and pregnancy, while its central laboratory range includes various clinical reagents and centrifuges. Its products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. The company has offices in the UK, Germany, USA, and Russia with a network of distributors across various countries. EKF Diagnostics is headquartered in Penarth, Wales, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EKF Diagnostics Holdings Plc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- EKF Diagnostics Holdings Plc Company Overview
- EKF Diagnostics Holdings Plc Company Snapshot
- EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- EKF Diagnostics Holdings Plc - Pipeline Analysis Overview
- Business Description
- EKF Diagnostics Holdings Plc - Key Facts
- EKF Diagnostics Holdings Plc - Major Products and Services
- EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
- EKF Diagnostics Holdings Plc Pipeline Products Overview
- B-HB POC Analyser
- B-HB POC Analyser Product Overview
- BIOSEN HbA1c Instrument
- BIOSEN HbA1c Instrument Product Overview
- DiaSpect Tm
- DiaSpect Tm Product Overview
- FractalDx - Acute Transplant Rejection Diagnostic
- FractalDx - Acute Transplant Rejection Diagnostic Product Overview
- Lactate Scout 4 - Clinic Use
- Lactate Scout 4 - Clinic Use Product Overview
- Point-Of-Care Test - Coagulation
- Point-Of-Care Test - Coagulation Product Overview
- Point-Of-Care Test - Vitamin D Test
- Point-Of-Care Test - Vitamin D Test Product Overview
- PointMan Assay - Breast Cancer
- PointMan Assay - Breast Cancer Product Overview
- PointMan Assay - Lung Cancer
- PointMan Assay - Lung Cancer Product Overview
- PointMan Assay - Skin Cancer
- PointMan Assay - Skin Cancer Product Overview
- PointMan PI3K DNA Enrichment Kit
- PointMan PI3K DNA Enrichment Kit Product Overview
- Quo-Lab - C-Reactive Protein
- Quo-Lab - C-Reactive Protein Product Overview
- RenaStat
- RenaStat Product Overview
- SensPoint
- SensPoint Product Overview
- Serum/Plasma Analyser
- Serum/Plasma Analyser Product Overview
- ß-Hydroxybutyrate LiquiColor Reagent
- ß-Hydroxybutyrate LiquiColor Reagent Product Overview
- Xtract Liquid Phase Extraction Device
- Xtract Liquid Phase Extraction Device Product Overview
- EKF Diagnostics Holdings Plc - Key Competitors
- EKF Diagnostics Holdings Plc - Key Employees
- EKF Diagnostics Holdings Plc - Key Employee Biographies
- EKF Diagnostics Holdings Plc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- EKF Diagnostics Holdings Plc, Recent Developments
- Jul 24, 2024: EKF Diagnostics Holdings announces Trading Update
- Jul 18, 2024: EKF Diagnostics Holdings : Upgraded Product launch and Contract Wins
- Jul 11, 2024: Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
- Jun 14, 2024: Medicare Issues Final Local Coverage Determination
- Apr 05, 2024: Renalytix : Change of Registered Address
- Mar 14, 2024: KidneyIntelX Included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)
- Feb 29, 2024: Renalytix Expands US Government Coverage for FDA Approved kidneyintelX.dkd Testing at $950
- Feb 09, 2024: Renalytix : Centers for Medicare & Medicaid Services Publishes Draft Local Coverage Determination for KidneyIntelX and kidneyintelX.dkd
- Jan 17, 2024: Renalytix : Update on kidneyIntelX.dkd Local Coverage Determination Consideration
- Jan 10, 2024: Renalytix : New published data for KidneyIntelX
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- EKF Diagnostics Holdings Plc Pipeline Products and Ongoing Clinical Trials Overview
- EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
- EKF Diagnostics Holdings Plc Pipeline Products by Indication
- EKF Diagnostics Holdings Plc, Key Facts
- EKF Diagnostics Holdings Plc, Major Products and Services
- EKF Diagnostics Holdings Plc Number of Pipeline Products by Development Stage
- EKF Diagnostics Holdings Plc Pipeline Products Summary by Development Stage
- B-HB POC Analyser - Product Status
- B-HB POC Analyser - Product Description
- BIOSEN HbA1c Instrument - Product Status
- BIOSEN HbA1c Instrument - Product Description
- DiaSpect Tm - Product Status
- DiaSpect Tm - Product Description
- FractalDx - Acute Transplant Rejection Diagnostic - Product Status
- FractalDx - Acute Transplant Rejection Diagnostic - Product Description
- Lactate Scout 4 - Clinic Use - Product Status
- Lactate Scout 4 - Clinic Use - Product Description
- Point-Of-Care Test - Coagulation - Product Status
- Point-Of-Care Test - Coagulation - Product Description
- Point-Of-Care Test - Vitamin D Test - Product Status
- Point-Of-Care Test - Vitamin D Test - Product Description
- PointMan Assay - Breast Cancer - Product Status
- PointMan Assay - Breast Cancer - Product Description
- PointMan Assay - Lung Cancer - Product Status
- PointMan Assay - Lung Cancer - Product Description
- PointMan Assay - Skin Cancer - Product Status
- PointMan Assay - Skin Cancer - Product Description
- PointMan PI3K DNA Enrichment Kit - Product Status
- PointMan PI3K DNA Enrichment Kit - Product Description
- Quo-Lab - C-Reactive Protein - Product Status
- Quo-Lab - C-Reactive Protein - Product Description
- RenaStat - Product Status
- RenaStat - Product Description
- SensPoint - Product Status
- SensPoint - Product Description
- Serum/Plasma Analyser - Product Status
- Serum/Plasma Analyser - Product Description
- ß-Hydroxybutyrate LiquiColor Reagent - Product Status
- ß-Hydroxybutyrate LiquiColor Reagent - Product Description
- Xtract Liquid Phase Extraction Device - Product Status
- Xtract Liquid Phase Extraction Device - Product Description
- EKF Diagnostics Holdings Plc, Key Employees
- EKF Diagnostics Holdings Plc, Key Employee Biographies
- EKF Diagnostics Holdings Plc, Other Locations
- EKF Diagnostics Holdings Plc, Subsidiaries
- Glossary
- EKF Diagnostics Holdings Plc Pipeline Products by Equipment Type
- EKF Diagnostics Holdings Plc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bio-Rad Laboratories Inc
- Quidel Corp
- Danaher Corp
- Becton Dickinson and Co
- Thermo Fisher Scientific Inc
- DiaSorin SpA
- bioMerieux SA
- Siemens Healthineers AG
- Roche Diagnostics International Ltd
- Qiagen NV
